IW-3300 rectal foam + Placebo
Phase 2Terminated 0 views this week 0 watching💤 Quiet
Interest: 21/100
21
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Interstitial Cystitis
Conditions
Interstitial Cystitis, Bladder Pain Syndrome
Trial Timeline
Mar 28, 2023 → Feb 6, 2025
NCT ID
NCT05740007About IW-3300 rectal foam + Placebo
IW-3300 rectal foam + Placebo is a phase 2 stage product being developed by Ironwood Pharmaceuticals for Interstitial Cystitis. The current trial status is terminated. This product is registered under clinical trial identifier NCT05740007. Target conditions include Interstitial Cystitis, Bladder Pain Syndrome.
What happened to similar drugs?
1 of 5 similar drugs in Interstitial Cystitis were approved
Approved (1) Terminated (2) Active (3)
✅Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mgJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
12
Activity
0
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05740007 | Phase 2 | Terminated |
Competing Products
20 competing products in Interstitial Cystitis